Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis

ÜSKÜDAR CANSU D., ÜSKÜDAR TEKE H., IŞIKSOY S., KORKMAZ C.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.21, sa.5, ss.1049-1059, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1111/1756-185x.13308
  • Dergi Adı: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1049-1059
  • Anahtar Kelimeler: autoimmune myelofibrosis, cytopenia, systemic lupus erythematosus, treatment, AUTOIMMUNE MYELOFIBROSIS, CLASSIFICATION, ABNORMALITIES, CRITERIA, UPDATE
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

AimCytopenia in the course of systemic lupus erythematosus (SLE) may be due to multiple factors. In this study, we aimed primarily to evaluate the detailed results of bone marrow (BM) biopsies of SLE patients, secondly to determine the myelofibrosis (MF) frequency and thirdly to compare BM morphologic findings as well as the clinical and laboratory parameters between groups (with MF and without MF) in cytopenic SLE patients.